Full Coverage

Teva Pharma Q3 Profit Up On Higher Sales - Update

rttnews.com
Nov 3, 2009
 
Story Timeline:  25 days

Generic drug maker Teva Pharmaceutical Industries Ltd. on Tuesday posted higher profit for the third quarter, boosted by strong sales of its multiple sclerosis drug Copaxone and Albuterol inhaler ProAir. Per share earnings,... [read full story]                    

powered by
Add Comment
Latest article on this story:

Teva Reports Strong Quarter (Zacks.com)

 yahoo.com Nov 4, 2009
First article on this story:

Israel Stocks: Israel stocks snap 4-day loss; drug firms in focus

 marketwatch.com Nov 2, 2009
Selected publications with coverage of this story:
marketwatch.com globes.co.il rttnews.com yahoo.com smartbrief.com philly.com finanznachrichten.de
RELATED
Found 26 documents:
                   

Teva Reports Strong Quarter (Zacks.com)

yahoo.com
Nov 4, 2009
 

Teva Pharmaceutical Industries Ltd. (NasdaqGS: TEVA - Strong sales of Copaxone and in the respiratory business helped drive earnings in the reported quarter. Net sales increased 25% to $3.55 billion, with the Barr acquisition...

powered by

Teva launches genetic allergy drug in US

globes.co.il
Nov 4, 2009
 

Annual US sales of the original drug, sanofi-aventis's Allegra-D, are $293 million. Globes' correspondent4 Nov 09 10:37 A day after reporting on a quarter with few generic launches, ) has announced the launch of a new generic...

powered by

UPDATE - Teva Q3 profit rises as Copaxone sales jump (at Reuters)

yahoo.com
Nov 3, 2009
 

Continues to seek acquisitions -CEO (Adds 2009, 2010 outlook, Nasdaq share reaction) By Tova Cohen TEL AVIV, Nov 3 (Reuters) - Teva Pharmaceutical Industries (TEVA.O), the world's largest generic drugmaker, reported higher...

powered by
                   

Teva Pharmaceutical Industries Limited Q3 2009 Earnings Call Transcript (at Seeking Alpha)

yahoo.com
Nov 3, 2009
 

November 03, 2009 | about: Teva Pharmaceutical Industries Limited Q3 2009 Earnings Call Executives Shlomo Yanai - Teva’s growth involves the top and bottom line in Q3 was driven by contributions from the across our many direct...

powered by
                   

My Two Healthcare Favorites (at Seeking Alpha)

yahoo.com
Nov 3, 2009
 

by: J. Royden Ward November 03, 2009 | about: One of the important objectives of health care reform is to increase the efficiency of the current system from top to bottom. Cutting costs and waste could save billions and reduce...

powered by
                   

UPDATE 3-Teva Q3 profit rises as Copaxone sales jump

smartbrief.com
Nov 3, 2009
 

By Tova Cohen TEL AVIV, Nov 3 (Reuters) - Teva Pharmaceutical Industries ( TEVA - news - people ) , the world's largest generic drugmaker, reported higher quarterly net profit on Tuesday, boosted by sales ...

powered by

Teva says Barr gave boost to 3Q profit

smartbrief.com
Nov 3, 2009
 

NEW YORK - Generic drug developer Teva Pharmaceutical Industries Ltd. said today that its profit rose 3 percent in the third quarter on sales of existing and added Barr products. Teva, whose U.S. headquarters are in North...

powered by

Teva says Barr gave boost to 3Q profit

philly.com
Nov 3, 2009
 

NEW YORK - Generic drug developer Teva Pharmaceutical Industries Ltd. said today that its profit rose 3 percent in the third quarter on sales of existing and added Barr products. Teva, whose U.S. headquarters are in North...

powered by
                   

Teva raises profit guidance

globes.co.il
Nov 3, 2009
 

The company now expects earnings per share of $4.40-4.60 in 2010. The stock market responded positively. After reporting record profits for the third quarter this morning, results greeted lukewarmly by the analysts, Teva raised...

powered by

Teva Pharmaceutical 3Q profit rises 3 percent

smartbrief.com
Nov 3, 2009
 

NEW YORK - Generic drug developer Teva Pharmaceutical Industries Ltd. said Tuesday its profit rose 3 percent in the third quarter on sales of existing and added Barr products. Teva's net income rose to $649 million, or 72 cents...

powered by
1 2 3 next